menu
    • menu

    Company profile for Kiniksa Pharmaceuticals

    NEW Drugs in Dev.: 7
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kiniksa is a biotech company with an experienced team that has advanced multiple product candidates in parallel that focus on a range of debilitating diseases with significant unmet medical need. We continue to explore expanding our pipeline in order to develop life-changing medicines for patients who need it most.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kiniksa PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue Lexington, MA 02421 USA
    Telephone
    Telephone
    (781) 431-9100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kiniksa.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiniksa Pharmaceuticals Provides Corporate Update
    Kiniksa Pharmaceuticals Provides Corporate Update

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216753/0/en/Kiniksa-Pharmaceuticals-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Kiniksa Pharma To Present At J.P. Morgan Healthcare Conference
    Kiniksa Pharma To Present At J.P. Morgan Healthcare Conference

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214886/0/en/Kiniksa-Pharmaceuticals-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Kiniksa Pharma Presents at Jefferies Healthcare Conference
    Kiniksa Pharma Presents at Jefferies Healthcare Conference

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186744/0/en/Kiniksa-Pharmaceuticals-to-Present-at-Jefferies-Global-Healthcare-Conference-in-London.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Kiniksa Pharma Reveals Q3 2025 Financials And Portfolio Updates
    Kiniksa Pharma Reveals Q3 2025 Financials And Portfolio Updates

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175273/0/en/Kiniksa-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Portfolio-Execution.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Kiniksa Pharma To Release Q3 2025 Financial Results On Oct 28
    Kiniksa Pharma To Release Q3 2025 Financial Results On Oct 28

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172416/0/en/Kiniksa-Pharmaceuticals-to-Report-Third-Quarter-2025-Financial-Results-on-October-28-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Kiniksa Pharma Gets U.S. Orphan Drug Status For KPL-387
    Kiniksa Pharma Gets U.S. Orphan Drug Status For KPL-387

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168566/0/en/Kiniksa-Pharmaceuticals-Announces-U-S-Orphan-Drug-Designation-for-KPL-387-for-the-Treatment-of-Pericarditis.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search